Cargando…
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
BACKGROUND: Fecal microbiota transplantation (FMT) is currently an approved treatment for recurrent and refractory Clostridioides difficile infection. However, its use in ulcerative colitis is at an early stage and significant gaps remain in our understanding of the mechanisms and logistics of its p...
Autores principales: | Sood, Ajit, Singh, Arshdeep, Midha, Vandana, Mahajan, Ramit, Kao, Dina, Rubin, David T, Bernstein, Charles N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802301/ https://www.ncbi.nlm.nih.gov/pubmed/36777748 http://dx.doi.org/10.1093/crocol/otaa067 |
Ejemplares similares
-
Incidental benefits after fecal microbiota transplant for ulcerative colitis
por: Mahajan, Ramit, et al.
Publicado: (2020) -
Endoscopy for assessment of mucosal healing in ulcerative colitis: time bound or response guided?
por: Sood, Ajit, et al.
Publicado: (2022) -
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
por: Sood, Ajit, et al.
Publicado: (2019) -
Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
por: Midha, Vandana, et al.
Publicado: (2018) -
Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)